These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 22341931

  • 1. Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy.
    Mattox AK, Lark AL, Adamson DC.
    Clin Neurol Neurosurg; 2012 May; 114(4):299-306. PubMed ID: 22341931
    [Abstract] [Full Text] [Related]

  • 2. Initial chemotherapy in gliomatosis cerebri.
    Sanson M, Cartalat-Carel S, Taillibert S, Napolitano M, Djafari L, Cougnard J, Gervais H, Laigle F, Carpentier A, Mokhtari K, Taillandier L, Chinot O, Duffau H, Honnorat J, Hoang-Xuan K, Delattre JY, ANOCEF group.
    Neurology; 2004 Jul 27; 63(2):270-5. PubMed ID: 15277619
    [Abstract] [Full Text] [Related]

  • 3. Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide.
    Levin N, Gomori JM, Siegal T.
    Neurology; 2004 Jul 27; 63(2):354-6. PubMed ID: 15277636
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.
    Inoue T, Kumabe T, Kanamori M, Sonoda Y, Watanabe M, Tominaga T.
    Neurosurg Rev; 2010 Apr 27; 34(2):197-208. PubMed ID: 21301914
    [Abstract] [Full Text] [Related]

  • 5. Gliomatosis cerebri treatment in 11 elderly patients.
    Piccirilli M, Landi A, Salvati M.
    J Exp Clin Cancer Res; 2006 Jun 27; 25(2):183-7. PubMed ID: 16918128
    [Abstract] [Full Text] [Related]

  • 6. Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis.
    Carroll KT, Hirshman B, Ali MA, Alattar AA, Brandel MG, Lochte B, Lanman T, Carter B, Chen CC.
    World Neurosurg; 2017 Jul 27; 103():186-193. PubMed ID: 28366748
    [Abstract] [Full Text] [Related]

  • 7. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM, Paratore S, Caltabiano R, Palmucci S, Parra HS, Privitera G, Motta F, Lanzafame S, Scaglione G, Longo A, Albanese V, Certo F.
    Neurosurg Focus; 2014 Dec 27; 37(6):E4. PubMed ID: 25434389
    [Abstract] [Full Text] [Related]

  • 8. Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution.
    Chiang KL, Chang KP, Lee YY, Huang PI, Hsu TR, Chen YW, Chang FC, Wong TT.
    Childs Nerv Syst; 2010 Aug 27; 26(8):1035-41. PubMed ID: 20217098
    [Abstract] [Full Text] [Related]

  • 9. Gliomatosis cerebri having a poor performance status without recurrence after radiotherapy: a single institutional experience.
    Jung TY, Yoon MS, Kim YH, Jung S, Kim IY, Jang WY, Moon KS, Lee KH, Kim SK.
    Clin Neurol Neurosurg; 2015 Mar 27; 130():1-5. PubMed ID: 25569296
    [Abstract] [Full Text] [Related]

  • 10. Response to low dose temozolomide in radiation induced gliomatosis cerebri.
    Hargrave D, Bouffet E, Gammon J, Becker L, Rutka J, Baruchel S.
    Med Pediatr Oncol; 2003 Dec 27; 41(6):562-4. PubMed ID: 14595716
    [No Abstract] [Full Text] [Related]

  • 11. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial.
    Verger E, Gil M, Yaya R, Viñolas N, Villà S, Pujol T, Quintó L, Graus F.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):185-91. PubMed ID: 15629610
    [Abstract] [Full Text] [Related]

  • 12. Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration.
    Lodi R, Setola E, Tonon C, Ambrosetto P, Franceschi E, Crinò L, Barbiroli B, Cortelli P.
    Magn Reson Imaging; 2003 Nov 01; 21(9):1003-7. PubMed ID: 14684203
    [Abstract] [Full Text] [Related]

  • 13. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
    Jalali R, Raut N, Arora B, Gupta T, Dutta D, Munshi A, Sarin R, Kurkure P.
    Int J Radiat Oncol Biol Phys; 2010 May 01; 77(1):113-8. PubMed ID: 19647954
    [Abstract] [Full Text] [Related]

  • 14. Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.
    Cao KI, Lebas N, Gerber S, Levy C, Le Scodan R, Bourgier C, Pierga JY, Gobillion A, Savignoni A, Kirova YM.
    Ann Oncol; 2015 Jan 01; 26(1):89-94. PubMed ID: 25355723
    [Abstract] [Full Text] [Related]

  • 15. [Temozolomide in patients with melanoma brain metastases treated with whole brain irradiation].
    Conill C, Fernández-Ibiza J, Malvehy J, Puig S, Sánchez M, Castel T.
    Med Clin (Barc); 2004 Mar 27; 122(11):413-5. PubMed ID: 15066248
    [Abstract] [Full Text] [Related]

  • 16. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
    Addeo R, De Rosa C, Faiola V, Leo L, Cennamo G, Montella L, Guarrasi R, Vincenzi B, Caraglia M, Del Prete S.
    Cancer; 2008 Nov 01; 113(9):2524-31. PubMed ID: 18798231
    [Abstract] [Full Text] [Related]

  • 17. Possible efficacy of temozolomide in a patient with gliomatosis cerebri.
    Benjelloun A, Delavelle J, Lazeyras F, Dietrich PY.
    Neurology; 2001 Nov 27; 57(10):1932-3. PubMed ID: 11723300
    [No Abstract] [Full Text] [Related]

  • 18. Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma.
    Kocher M, Frommolt P, Borberg SK, Rühl U, Steingräber M, Niewald M, Staar S, Stuschke M, Becker G, Fischedick AR, Herfarth K, Grauthoff H, Müller RP.
    Strahlenther Onkol; 2008 Nov 27; 184(11):572-9. PubMed ID: 19016015
    [Abstract] [Full Text] [Related]

  • 19. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
    Ishikawa E, Muragaki Y, Yamamoto T, Maruyama T, Tsuboi K, Ikuta S, Hashimoto K, Uemae Y, Ishihara T, Matsuda M, Matsutani M, Karasawa K, Nakazato Y, Abe T, Ohno T, Matsumura A.
    J Neurosurg; 2014 Sep 27; 121(3):543-53. PubMed ID: 24995786
    [Abstract] [Full Text] [Related]

  • 20. Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.
    Malmström A, Poulsen HS, Grønberg BH, Stragliotto G, Hansen S, Asklund T, Holmlund B, Łysiak M, Dowsett J, Kristensen BW, Söderkvist P, Rosell J, Henriksson R, Nordic Clinical Brain Tumor Study Group (NCBTSG).
    Acta Oncol; 2017 Dec 27; 56(12):1776-1785. PubMed ID: 28675067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.